Genoheal announced on the 10th that it had received approval
from the Ministry of Food and Drug Safety in December of last year
for a Phase
Iclinicalal trial targeting poor ovarian responders in Korea. The company plans
to follow this with a clinical trial at women’s hospitals
and other domestic
clinical trial institutes. They have already started making preparations for the
confirmatory clinical trial since the last quarter,
including the submission of
clinical trial documents. With the latest approval, starting the first quarter
this year in Korea…
더보기
기자 : 고동현 ㅣ 보도일자 : 2022.01.10
출처 : 메디컬투데이 (http://www.mdtoday.co.kr/)
